Oncotarget

DPP4 Inhibitors for Target Therapy Resistance in Renal Cell Carcinoma

Sep 20, 2023
Researchers discuss the potential repurposing of DPP4 inhibitors for target therapy resistance in renal cell carcinoma, focusing on their impact on Sunitinab efficacy.
Ask episode
Chapters
Transcript
Episode notes